Peptides in Anxiety Research
Several research peptides demonstrate anxiolytic (anxiety-reducing) properties through various neurological mechanisms. These compounds offer targeted approaches to studying anxiety pathways without the broad receptor effects of traditional anxiolytics.
Selank: The Anxiolytic Peptide
Selank is a synthetic analog of the immunomodulatory peptide tuftsin with potent anxiolytic properties. Mechanisms include: modulation of GABA-A receptor expression, serotonin and dopamine metabolism influence, BDNF (brain-derived neurotrophic factor) upregulation, and IL-6 cytokine modulation. Selank is typically researched via nasal administration for CNS access.
Semax: Nootropic With Anxiolytic Properties
Semax is primarily a nootropic peptide but demonstrates secondary anxiolytic effects through BDNF and NGF modulation in the limbic system. Its cognitive-enhancing properties may indirectly reduce anxiety through improved stress coping.
BPC-157: Gut-Brain Anxiety Research
BPC-157 research demonstrates anxiolytic effects potentially mediated through the gut-brain axis. Studies show interactions with the dopaminergic and serotonergic systems, suggesting a gastric peptide can influence central anxiety pathways.
Mechanisms of Peptide Anxiolysis
Unlike benzodiazepines (GABA-A allosteric modulators), peptide anxiolytics work through diverse mechanisms: neurotrophic factor modulation (BDNF, NGF), monoamine neurotransmitter balance, HPA axis regulation, neuroinflammation reduction, and synaptic plasticity enhancement.
Related Articles: Selank Benefits | Semax Benefits | Best Nootropic Peptides
For research use only. Browse nootropic peptides at Proxiva Labs with third-party COAs.